Senior Manager, Strategic Finance & Corporate Valuation

At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees. Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so. Does this inspire you and feel like a fit? Then we would love to have you join us! The Role Senior Manager, Strategic Finance & Corporate Valuation (SFCV) will report to the Associate Director, Strategic Finance & Corporate Valuation Support projects, initiatives, and analyses to inform strategic capital allocation and resourcing decisions Support financial modeling and valuation analyses for internal portfolio and growth initiatives Support financial modeling, valuation analyses, and investment case development for BD/M&A Analyze industry trends/themes and peer company developments and synthesize implications to Genmab’s business and equity value Collaborate closely with other Finance team functions, Strategy & Corporate Development, Business Development & Licensing, R&D, Commercialization, Human Resources, and others Responsibilities Support SFCV’s goals & objectives aligned with the company’s overarching strategy and 2030 Vision Support financial modeling and perform valuation analyses for organic and inorganic growth opportunities Track performance against plan for transformation initiatives to provide transparency and accountability together with FP&A Report on industry trends and peer company developments, translate their impact on Genmab, and improve overall strategic decision-making quality Support portfolio strategy and investment decisions through formal business case development and partnership with R&D, Commercialization, and Corporate & Business Development Partner with Corporate & Business Development to support execution and implementation of strategic transactions Support long range planning, corporate strategy development, implementation, and execution Work arrangement: This role offers flexibility to work away from the office for 20%–40% of a typical schedule. Employees may use this work schedule in increments of single days or multiple consecutive days, provided it does not exceed 40% within a 60-day period, and is approved by the hiring manager Qualifications and Requirements Qualifications Bachelor's degree in Finance, Accounting, Economics, Business, or related field ; MBA, degree preferred 4+ years of progressive experience in investment banking, private equity or Hedge funds. Prior healthcare investment banking and/or buyside (PE/HF) experience highly preferred Prior healthcare equity research experience or corporate development with strong financial modeling skills also considered Requirements Passionate about the life sciences, and Genmab’s purpose and mission Demonstrated knowledge of financial modeling, valuation, corporate finance, and the capital markets Strong interest in global biotech/pharma industry Structured problem-solving skills Clear and articulate communicator Highly organized, attentive to detail, and results-driven For US based candidates, the proposed salary band for this position is as follows: $138,720.00---$208,080.00 The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives. When you join Genmab, you’re joining a culture that supports your physical, financial, social, and emotional wellness. Within the first year, regular full-time U.S. employees are eligible for: 401(k) Plan: 100% match on the first 6% of contributions Health Benefits: Two medical plan options (including HDHP with HSA), dental, and vision insurance Voluntary Plans: Critical illness, accident, and hospital indemnity insurance Time Off: Paid vacation, sick leave, holidays, and 12 weeks of discretionary paid parental leave Support Resources: Access to child and adult backup care, family support programs, financial wellness tools, and emotional well-being support Additional Perks: Commuter benefits, tuition reimbursement, and a Lifestyle Spending Account for wellness and personal expenses About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines. Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X. Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com). Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract. Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO™) antibody medicines. Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.